验证数据展示
经过测试的应用
Positive WB detected in | human heart tissue, human platelets |
Mouse monoclonal antibodies of IgM isotype can be detected with "anti-mouse IgG (H+L)" secondary antibodies.
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:1000-1:6000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
67651-1-Ig targets PDLIM5 in WB, ELISA applications and shows reactivity with Human samples.
经测试应用 | WB, ELISA Application Description |
经测试反应性 | Human |
免疫原 | PDLIM5 fusion protein Ag25059 种属同源性预测 |
宿主/亚型 | Mouse / IgM |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | PDZ and LIM domain 5 |
别名 | ENH, ENH1, Enigma homolog, L9, LIM, PDLIM5, PDZ and LIM domain 5, PDZ and LIM domain protein 5 |
计算分子量 | 64 kDa |
观测分子量 | 63-69 kDa |
GenBank蛋白编号 | BC008741 |
基因名称 | PDLIM5 |
Gene ID (NCBI) | 10611 |
RRID | AB_2882850 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Euglobulin precipitation |
UNIPROT ID | Q96HC4 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
PDLIM5 (PDZ and LIM domain 5), formerly known as enigma homolog (ENH), is a cytoplasmic protein containing PDZ domain and LIM domain at N terminus and C terminus, respectively. PDLIM5 gene generates several splicing variants, EZH1 to EZH4. The long isoform, ENH1, is widely expressed in various tissues including heart, brain, spleen, liver and kidney. In comparison, shorter isoforms that lack the LIM motifs are expressed in cardiac (ENH3) and skeletal muscle (ENH2, ENH3, and ENH4). ENH1 is essential for differentiation of striated muscles through interaction with other proteins. In addition, PDLIM5 is also involved in mood disorders, such as schizophrenia, bipolar disorder, and major depression.
实验方案
Product Specific Protocols | |
---|---|
WB protocol for PDLIM5 antibody 67651-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |